160 related articles for article (PubMed ID: 11532632)
21. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation.
Lutz C; Massenkeil G; Nagy M; Neuburger S; Tamm I; Rosen O; Dörken B; Arnold R
Bone Marrow Transplant; 2008 May; 41(9):805-12. PubMed ID: 18195682
[TBL] [Abstract][Full Text] [Related]
22. DLI or second transplant.
Greinix HT
Ann Hematol; 2002; 81 Suppl 2():S34-5. PubMed ID: 12611068
[TBL] [Abstract][Full Text] [Related]
23. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
24. STI571 (GLIVEC) induced hematologic, cytogenetic and molecular remission in a cml patient relapsing with accelerated phase after allogeneic stem cell transplantation.
Consoli U; Milone G; Guido G; Consoli C; Palumbo GA; Giustolisi R
Haematologica; 2002 Dec; 87(12):ECR37. PubMed ID: 12495908
[No Abstract] [Full Text] [Related]
25. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis.
Bartolozzi B; Bosi A; Orsi C
Cancer; 2007 Jan; 109(2):343; author reply 344. PubMed ID: 17154182
[No Abstract] [Full Text] [Related]
27. Longer follow-up confirms major improvement in outcome in children and adolescents with Philadelphia chromosome acute lymphoblastic leukaemia treated with continuous imatinib and haematopoietic stem cell transplantation. Results from the Spanish Cooperative Study SHOP/ALL-2005.
Rives S; Camós M; Estella J; Gómez P; Moreno MJ; Vivanco JL; Melo M; Fernández-Delgado R; Verdeguer A; Fernández-Teijeiro A; Lendínez F; López-Almaraz R; Uriz JJ; Badell I;
Br J Haematol; 2013 Aug; 162(3):419-21. PubMed ID: 23668628
[No Abstract] [Full Text] [Related]
28. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis.
Yanada M; Matsuo K; Suzuki T; Naoe T
Cancer; 2006 Jun; 106(12):2657-63. PubMed ID: 16703597
[TBL] [Abstract][Full Text] [Related]
29. Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation.
Wassmann B; Klein SA; Scheuring U; Pfeifer H; Martin H; Gschaidmeier H; Hoelzer D; Ottmann OG
Bone Marrow Transplant; 2001 Oct; 28(7):721-4. PubMed ID: 11704799
[TBL] [Abstract][Full Text] [Related]
30. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Biol Blood Marrow Transplant; 2004 Mar; 10(3):195-203. PubMed ID: 14993885
[TBL] [Abstract][Full Text] [Related]
31. Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation.
Ishikawa J; Maeda T; Kashiwagi H; Yoshida H; Takahashi I; Kawamoto SI; Yamada M; Kato H; Nishiura T; Tomiyama Y; Matsuzawa Y
Bone Marrow Transplant; 2003 Jun; 31(11):1057-9. PubMed ID: 12774060
[TBL] [Abstract][Full Text] [Related]
32. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
[TBL] [Abstract][Full Text] [Related]
33. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
Loren AW; Porter DL
Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
[TBL] [Abstract][Full Text] [Related]
34. Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantation.
Wassmann B; Scheuring U; Thiede C; Pfeifer H; Bornhäuser M; Griesinger F; Hochhaus A; Schleyer E; Gschaidmeier H; Hoelzer D; Ottmann OG
Bone Marrow Transplant; 2003 Apr; 31(7):611-4. PubMed ID: 12692630
[TBL] [Abstract][Full Text] [Related]
35. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Bachanova V; Weisdorf D
Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
[TBL] [Abstract][Full Text] [Related]
36. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
[TBL] [Abstract][Full Text] [Related]
37. Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
Wernstedt P; Brune M; Andersson PO; Gustavsson B; Stockelberg D; Wadenvik H
Bone Marrow Transplant; 2002 Dec; 30(12):971-3. PubMed ID: 12476293
[TBL] [Abstract][Full Text] [Related]
38. Recurrence of lymphoid blast crisis over 20 years after successful sibling allo-SCT for CML: short lived complete cytogenetic response to imatinib.
Irvine DA; Shepherd JD
Bone Marrow Transplant; 2009 Aug; 44(4):267-8. PubMed ID: 19234506
[No Abstract] [Full Text] [Related]
39. Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment.
Dazzi F; Fozza C
Best Pract Res Clin Haematol; 2007 Jun; 20(2):311-27. PubMed ID: 17448964
[TBL] [Abstract][Full Text] [Related]
40. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shin HJ; Chung JS; Cho GJ
Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
